Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
Top Cited Papers
- 1 May 2008
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 371 (9624), 1579-1586
- https://doi.org/10.1016/s0140-6736(08)60690-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cellsLeukemia, 2007
- How I treat refractory acute GVHDBlood, 2007
- Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergyBlood, 2005
- Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanismsAmerican Journal of Physiology-Renal Physiology, 2005
- Cotransplantation of HLA-Identical Sibling Culture-Expanded Mesenchymal Stem Cells and Hematopoietic Stem Cells in Hematologic Malignancy PatientsTransplantation and Cellular Therapy, 2005
- Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradationBlood, 2004
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Characterization of cells with osteogenic potential from human marrowBone, 1992
- DEATH BY GRAFT-VERSUS-HOST DISEASE ASSOCIATED WITH HLA MISMATCH, HIGH RECIPIENT AGE, LOW MARROW CELL DOSE, AND SPLENECTOMYTransplantation, 1985
- MARROW TRANSPLANTATION FOR PATIENTS IN THE CHRONIC PHASE OF CHRONIC GRANULOCYTIC LEUKAEMIAThe Lancet, 1982